Enrico Ferrero - GlaxoSmithKline, Target Sci, Computat Biol, Stevenage, Herts, England

基本信息

浏览量：6

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 28 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Benchmarking tools for transcription factor prioritization

Leonor Schubert Santana, Alejandro Reyes, Sebastian Hoersch,Enrico Ferrero, Christian Kolter, Swann Gaulis, Sebastian Steinhauser

crossref（2024）

引用0浏览0引用

Efficacy and safety of remibrutinib, a selective potent oral BTK inhibitor, in Sj?gren's syndrome: results from a randomised, double-blind, placebo-controlled phase 2 trial

Thomas Doerner,Martin Kaul,Antonia Szanto,Jui-Cheng Tseng,Athena S. Papas, Ilona Pylvaenaeinen, Malika Hanser,Nasri Abdallah,Andrea Grioni,Aida Santos Da Costa,Enrico Ferrero,Peter Gergely,

ANNALS OF THE RHEUMATIC DISEASESno. 3 (2024): 360-371

引用0浏览0引用

Response to anti-IL17 therapy in inflammatory disease is not strongly impacted by genetic background

Cong Zhang,Konstantin Shestopaloff,Benjamin Hollis,Chun Hei Kwok,Claudia Hon,Nicole Hartmann, Chengeng Tian,Magdalena Wozniak,Luis Santos,Dominique West,Stephen Gardiner,Ann-Marie Mallon,

American journal of human genetics（2023）

引用0浏览0WOS引用

828 Early intervention with secukinumab may affect the establishment of tissue memory in psoriasis: Results from a DNA methylation analysis

C. Conrad, S. Gaulis, K. Bier,J. Gudjonsson, L. Eidsmo, J. Kärner,L. Iversen,A. Costanzo, P. Jagiello, F. Kolbinger, F. Lohmann,E. Ferrero

Journal of Investigative Dermatologyno. 5 (2023): S142-S142

引用0浏览0引用

Preclinical characterization of the Toll-like receptor 7/8 antagonist MHV370 for lupus therapy

Stuart Hawtin,Cédric André, Géraldine Collignon-Zipfel,Simone Appenzeller,Bettina Bannert, Lea Baumgartner,Damian Beck,Claudia Betschart,Thomas Boulay,Hermine I Brunner, Melanie Ceci,Jonathan Deane,

Cell reports. Medicineno. 5 (2023): 101036-101036

引用2浏览0WOS引用

Efficacy and safety of remibrutinib, a selective potent oral BTK inhibitor, in Sj?gren's syndrome: results from a randomised, double-blind, placebo-controlled phase 2 trial

Thomas Doerner,Martin Kaul,Antonia Szanto,Jui-Cheng Tseng,Athena S. Papas, Ilona Pylvaenaeinen, Malika Hanser,Nasri Abdallah,Andrea Grioni,Aida Santos Da Costa,Enrico Ferrero,Peter Gergely,

Annals of the rheumatic diseases（2023）

引用0浏览0WOS引用

Remibrutinib Inhibits Neuroinflammation Driven by B Cells and Myeloid Cells in Preclinical Models of Multiple Sclerosis

Bernd Kieseier,Bruno Cenni,Barbara Nuesslein-Hildesheim,Enrico Ferrero, Catherine Huck, Denis Eichlisberger,Marina Ziehn

MULTIPLE SCLEROSIS JOURNAL（2023）

引用0浏览0引用

Analysis of serum proteomics data identifies a quantitative association between beta-defensin 2 at baseline and clinical response to IL-17 blockade in psoriatic arthritis

Mathias Cardner,Danny Tuckwell,Anna Kostikova,Pascal Forrer,Richard M. Siegel, Alain Marti,Marc Vandemeulebroecke,Enrico Ferrero

RMD openno. 2 (2023): e003042-e003042

引用2浏览0WOS引用

Analysis of Serum Proteomics Data Identifies Beta-Defensin 2 as a Predictive Biomarker of Clinical Response to IL-17 Blockade in Psoriatic Arthritis

Mathias Cardner,Danny Tuckwell,Anna Kostikova,Pascal Forrer,Richard Siegel, Alain Marti,Marc Vandemeulebroecke,Enrico Ferrero

ARTHRITIS & RHEUMATOLOGY (2022): 4262-4264

引用0浏览0引用

Translational precision medicine: an industry perspective

Dominik Hartl,Valeria de Luca, Anna Kostikova,Jason Laramie,Scott Kennedy,Enrico Ferrero,Richard Siegel, Martin Fink, Sohail Ahmed, John Millholland,Alexander Schuhmacher,Markus Hinder,

Journal of Translational Medicine（2021）

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn